English
简体中文
Total: £ 56.28
Published Date: 2025-08-22 | Pages: 134 | Tables: 125 | Medical Care
The global market for Precision Medicine was estimated to be worth US$ 142800 million in 2024 and is forecast to a readjusted size of US$ 268890 million by 2031 with a CAGR of 9.6% during the forecast period 2025-2031.
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.
Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.
Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.
This report aims to provide a comprehensive presentation of the global market for Precision Medicine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Precision Medicine by region & country, by Type, and by Application.
The Precision Medicine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Medicine.
Market Segmentation
By Company
Johnson & Johnson
Roche
Labcorp
Abbott Laboratories
Novartis
Illumina
GE Healthcare
Intel Corporation
Biomrieux Sa
Cepheid
IBM
Qiagen
Thermo Fisher Scientific
Randox Laboratories
Almac Group
Healthcore
Segment by Type
Diagnostics
Therapies
Segment by Application
Oncology
Neurosciences
Immunology
Respiratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Precision Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Precision Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Precision Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Precision Medicine Product Introduction
1.2 Global Precision Medicine Market Size Forecast (2020-2031)
1.3 Precision Medicine Market Trends & Drivers
1.3.1 Precision Medicine Industry Trends
1.3.2 Precision Medicine Market Drivers & Opportunity
1.3.3 Precision Medicine Market Challenges
1.3.4 Precision Medicine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Precision Medicine Players Revenue Ranking (2024)
2.2 Global Precision Medicine Revenue by Company (2020-2025)
2.3 Key Companies Precision Medicine Manufacturing Base Distribution and Headquarters
2.4 Key Companies Precision Medicine Product Offered
2.5 Key Companies Time to Begin Mass Production of Precision Medicine
2.6 Precision Medicine Market Competitive Analysis
2.6.1 Precision Medicine Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Precision Medicine Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Medicine as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Diagnostics
3.1.2 Therapies
3.2 Global Precision Medicine Sales Value by Type
3.2.1 Global Precision Medicine Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Precision Medicine Sales Value, by Type (2020-2031)
3.2.3 Global Precision Medicine Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oncology
4.1.2 Neurosciences
4.1.3 Immunology
4.1.4 Respiratory
4.1.5 Others
4.2 Global Precision Medicine Sales Value by Application
4.2.1 Global Precision Medicine Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Precision Medicine Sales Value, by Application (2020-2031)
4.2.3 Global Precision Medicine Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Precision Medicine Sales Value by Region
5.1.1 Global Precision Medicine Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Precision Medicine Sales Value by Region (2020-2025)
5.1.3 Global Precision Medicine Sales Value by Region (2026-2031)
5.1.4 Global Precision Medicine Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Precision Medicine Sales Value, 2020-2031
5.2.2 North America Precision Medicine Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Precision Medicine Sales Value, 2020-2031
5.3.2 Europe Precision Medicine Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Precision Medicine Sales Value, 2020-2031
5.4.2 Asia Pacific Precision Medicine Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Precision Medicine Sales Value, 2020-2031
5.5.2 South America Precision Medicine Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Precision Medicine Sales Value, 2020-2031
5.6.2 Middle East & Africa Precision Medicine Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Precision Medicine Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Precision Medicine Sales Value, 2020-2031
6.3 United States
6.3.1 United States Precision Medicine Sales Value, 2020-2031
6.3.2 United States Precision Medicine Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Precision Medicine Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Precision Medicine Sales Value, 2020-2031
6.4.2 Europe Precision Medicine Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Precision Medicine Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Precision Medicine Sales Value, 2020-2031
6.5.2 China Precision Medicine Sales Value by Type (%), 2024 VS 2031
6.5.3 China Precision Medicine Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Precision Medicine Sales Value, 2020-2031
6.6.2 Japan Precision Medicine Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Precision Medicine Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Precision Medicine Sales Value, 2020-2031
6.7.2 South Korea Precision Medicine Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Precision Medicine Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Precision Medicine Sales Value, 2020-2031
6.8.2 Southeast Asia Precision Medicine Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Precision Medicine Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Precision Medicine Sales Value, 2020-2031
6.9.2 India Precision Medicine Sales Value by Type (%), 2024 VS 2031
6.9.3 India Precision Medicine Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Profile
7.1.2 Johnson & Johnson Main Business
7.1.3 Johnson & Johnson Precision Medicine Products, Services and Solutions
7.1.4 Johnson & Johnson Precision Medicine Revenue (US$ Million) & (2020-2025)
7.1.5 Johnson & Johnson Recent Developments
7.2 Roche
7.2.1 Roche Profile
7.2.2 Roche Main Business
7.2.3 Roche Precision Medicine Products, Services and Solutions
7.2.4 Roche Precision Medicine Revenue (US$ Million) & (2020-2025)
7.2.5 Roche Recent Developments
7.3 Labcorp
7.3.1 Labcorp Profile
7.3.2 Labcorp Main Business
7.3.3 Labcorp Precision Medicine Products, Services and Solutions
7.3.4 Labcorp Precision Medicine Revenue (US$ Million) & (2020-2025)
7.3.5 Labcorp Recent Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Profile
7.4.2 Abbott Laboratories Main Business
7.4.3 Abbott Laboratories Precision Medicine Products, Services and Solutions
7.4.4 Abbott Laboratories Precision Medicine Revenue (US$ Million) & (2020-2025)
7.4.5 Abbott Laboratories Recent Developments
7.5 Novartis
7.5.1 Novartis Profile
7.5.2 Novartis Main Business
7.5.3 Novartis Precision Medicine Products, Services and Solutions
7.5.4 Novartis Precision Medicine Revenue (US$ Million) & (2020-2025)
7.5.5 Novartis Recent Developments
7.6 Illumina
7.6.1 Illumina Profile
7.6.2 Illumina Main Business
7.6.3 Illumina Precision Medicine Products, Services and Solutions
7.6.4 Illumina Precision Medicine Revenue (US$ Million) & (2020-2025)
7.6.5 Illumina Recent Developments
7.7 GE Healthcare
7.7.1 GE Healthcare Profile
7.7.2 GE Healthcare Main Business
7.7.3 GE Healthcare Precision Medicine Products, Services and Solutions
7.7.4 GE Healthcare Precision Medicine Revenue (US$ Million) & (2020-2025)
7.7.5 GE Healthcare Recent Developments
7.8 Intel Corporation
7.8.1 Intel Corporation Profile
7.8.2 Intel Corporation Main Business
7.8.3 Intel Corporation Precision Medicine Products, Services and Solutions
7.8.4 Intel Corporation Precision Medicine Revenue (US$ Million) & (2020-2025)
7.8.5 Intel Corporation Recent Developments
7.9 Biomrieux Sa
7.9.1 Biomrieux Sa Profile
7.9.2 Biomrieux Sa Main Business
7.9.3 Biomrieux Sa Precision Medicine Products, Services and Solutions
7.9.4 Biomrieux Sa Precision Medicine Revenue (US$ Million) & (2020-2025)
7.9.5 Biomrieux Sa Recent Developments
7.10 Cepheid
7.10.1 Cepheid Profile
7.10.2 Cepheid Main Business
7.10.3 Cepheid Precision Medicine Products, Services and Solutions
7.10.4 Cepheid Precision Medicine Revenue (US$ Million) & (2020-2025)
7.10.5 Cepheid Recent Developments
7.11 IBM
7.11.1 IBM Profile
7.11.2 IBM Main Business
7.11.3 IBM Precision Medicine Products, Services and Solutions
7.11.4 IBM Precision Medicine Revenue (US$ Million) & (2020-2025)
7.11.5 IBM Recent Developments
7.12 Qiagen
7.12.1 Qiagen Profile
7.12.2 Qiagen Main Business
7.12.3 Qiagen Precision Medicine Products, Services and Solutions
7.12.4 Qiagen Precision Medicine Revenue (US$ Million) & (2020-2025)
7.12.5 Qiagen Recent Developments
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Profile
7.13.2 Thermo Fisher Scientific Main Business
7.13.3 Thermo Fisher Scientific Precision Medicine Products, Services and Solutions
7.13.4 Thermo Fisher Scientific Precision Medicine Revenue (US$ Million) & (2020-2025)
7.13.5 Thermo Fisher Scientific Recent Developments
7.14 Randox Laboratories
7.14.1 Randox Laboratories Profile
7.14.2 Randox Laboratories Main Business
7.14.3 Randox Laboratories Precision Medicine Products, Services and Solutions
7.14.4 Randox Laboratories Precision Medicine Revenue (US$ Million) & (2020-2025)
7.14.5 Randox Laboratories Recent Developments
7.15 Almac Group
7.15.1 Almac Group Profile
7.15.2 Almac Group Main Business
7.15.3 Almac Group Precision Medicine Products, Services and Solutions
7.15.4 Almac Group Precision Medicine Revenue (US$ Million) & (2020-2025)
7.15.5 Almac Group Recent Developments
7.16 Healthcore
7.16.1 Healthcore Profile
7.16.2 Healthcore Main Business
7.16.3 Healthcore Precision Medicine Products, Services and Solutions
7.16.4 Healthcore Precision Medicine Revenue (US$ Million) & (2020-2025)
7.16.5 Healthcore Recent Developments
8 Industry Chain Analysis
8.1 Precision Medicine Industrial Chain
8.2 Precision Medicine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Precision Medicine Sales Model
8.5.2 Sales Channel
8.5.3 Precision Medicine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Precision Medicine Market Trends
Table 2. Precision Medicine Market Drivers & Opportunity
Table 3. Precision Medicine Market Challenges
Table 4. Precision Medicine Market Restraints
Table 5. Global Precision Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Precision Medicine Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Precision Medicine Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Precision Medicine Product Type
Table 9. Key Companies Time to Begin Mass Production of Precision Medicine
Table 10. Global Precision Medicine Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Medicine as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Precision Medicine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Precision Medicine Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Precision Medicine Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Precision Medicine Sales Market Share in Value by Type (2020-2025)
Table 17. Global Precision Medicine Sales Market Share in Value by Type (2026-2031)
Table 18. Global Precision Medicine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Precision Medicine Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Precision Medicine Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Precision Medicine Sales Market Share in Value by Application (2020-2025)
Table 22. Global Precision Medicine Sales Market Share in Value by Application (2026-2031)
Table 23. Global Precision Medicine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Precision Medicine Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Precision Medicine Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Precision Medicine Sales Value by Region (2020-2025) & (%)
Table 27. Global Precision Medicine Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Precision Medicine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Precision Medicine Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Precision Medicine Sales Value, (2026-2031) & (US$ Million)
Table 31. Johnson & Johnson Basic Information List
Table 32. Johnson & Johnson Description and Business Overview
Table 33. Johnson & Johnson Precision Medicine Products, Services and Solutions
Table 34. Revenue (US$ Million) in Precision Medicine Business of Johnson & Johnson (2020-2025)
Table 35. Johnson & Johnson Recent Developments
Table 36. Roche Basic Information List
Table 37. Roche Description and Business Overview
Table 38. Roche Precision Medicine Products, Services and Solutions
Table 39. Revenue (US$ Million) in Precision Medicine Business of Roche (2020-2025)
Table 40. Roche Recent Developments
Table 41. Labcorp Basic Information List
Table 42. Labcorp Description and Business Overview
Table 43. Labcorp Precision Medicine Products, Services and Solutions
Table 44. Revenue (US$ Million) in Precision Medicine Business of Labcorp (2020-2025)
Table 45. Labcorp Recent Developments
Table 46. Abbott Laboratories Basic Information List
Table 47. Abbott Laboratories Description and Business Overview
Table 48. Abbott Laboratories Precision Medicine Products, Services and Solutions
Table 49. Revenue (US$ Million) in Precision Medicine Business of Abbott Laboratories (2020-2025)
Table 50. Abbott Laboratories Recent Developments
Table 51. Novartis Basic Information List
Table 52. Novartis Description and Business Overview
Table 53. Novartis Precision Medicine Products, Services and Solutions
Table 54. Revenue (US$ Million) in Precision Medicine Business of Novartis (2020-2025)
Table 55. Novartis Recent Developments
Table 56. Illumina Basic Information List
Table 57. Illumina Description and Business Overview
Table 58. Illumina Precision Medicine Products, Services and Solutions
Table 59. Revenue (US$ Million) in Precision Medicine Business of Illumina (2020-2025)
Table 60. Illumina Recent Developments
Table 61. GE Healthcare Basic Information List
Table 62. GE Healthcare Description and Business Overview
Table 63. GE Healthcare Precision Medicine Products, Services and Solutions
Table 64. Revenue (US$ Million) in Precision Medicine Business of GE Healthcare (2020-2025)
Table 65. GE Healthcare Recent Developments
Table 66. Intel Corporation Basic Information List
Table 67. Intel Corporation Description and Business Overview
Table 68. Intel Corporation Precision Medicine Products, Services and Solutions
Table 69. Revenue (US$ Million) in Precision Medicine Business of Intel Corporation (2020-2025)
Table 70. Intel Corporation Recent Developments
Table 71. Biomrieux Sa Basic Information List
Table 72. Biomrieux Sa Description and Business Overview
Table 73. Biomrieux Sa Precision Medicine Products, Services and Solutions
Table 74. Revenue (US$ Million) in Precision Medicine Business of Biomrieux Sa (2020-2025)
Table 75. Biomrieux Sa Recent Developments
Table 76. Cepheid Basic Information List
Table 77. Cepheid Description and Business Overview
Table 78. Cepheid Precision Medicine Products, Services and Solutions
Table 79. Revenue (US$ Million) in Precision Medicine Business of Cepheid (2020-2025)
Table 80. Cepheid Recent Developments
Table 81. IBM Basic Information List
Table 82. IBM Description and Business Overview
Table 83. IBM Precision Medicine Products, Services and Solutions
Table 84. Revenue (US$ Million) in Precision Medicine Business of IBM (2020-2025)
Table 85. IBM Recent Developments
Table 86. Qiagen Basic Information List
Table 87. Qiagen Description and Business Overview
Table 88. Qiagen Precision Medicine Products, Services and Solutions
Table 89. Revenue (US$ Million) in Precision Medicine Business of Qiagen (2020-2025)
Table 90. Qiagen Recent Developments
Table 91. Thermo Fisher Scientific Basic Information List
Table 92. Thermo Fisher Scientific Description and Business Overview
Table 93. Thermo Fisher Scientific Precision Medicine Products, Services and Solutions
Table 94. Revenue (US$ Million) in Precision Medicine Business of Thermo Fisher Scientific (2020-2025)
Table 95. Thermo Fisher Scientific Recent Developments
Table 96. Randox Laboratories Basic Information List
Table 97. Randox Laboratories Description and Business Overview
Table 98. Randox Laboratories Precision Medicine Products, Services and Solutions
Table 99. Revenue (US$ Million) in Precision Medicine Business of Randox Laboratories (2020-2025)
Table 100. Randox Laboratories Recent Developments
Table 101. Almac Group Basic Information List
Table 102. Almac Group Description and Business Overview
Table 103. Almac Group Precision Medicine Products, Services and Solutions
Table 104. Revenue (US$ Million) in Precision Medicine Business of Almac Group (2020-2025)
Table 105. Almac Group Recent Developments
Table 106. Healthcore Basic Information List
Table 107. Healthcore Description and Business Overview
Table 108. Healthcore Precision Medicine Products, Services and Solutions
Table 109. Revenue (US$ Million) in Precision Medicine Business of Healthcore (2020-2025)
Table 110. Healthcore Recent Developments
Table 111. Key Raw Materials Lists
Table 112. Raw Materials Key Suppliers Lists
Table 113. Precision Medicine Downstream Customers
Table 114. Precision Medicine Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Precision Medicine Product Picture
Figure 2. Global Precision Medicine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Precision Medicine Sales Value (2020-2031) & (US$ Million)
Figure 4. Precision Medicine Report Years Considered
Figure 5. Global Precision Medicine Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Precision Medicine Revenue in 2024
Figure 7. Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Diagnostics Picture
Figure 9. Therapies Picture
Figure 10. Global Precision Medicine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 11. Global Precision Medicine Sales Value Market Share by Type, 2024 & 2031
Figure 12. Product Picture of Oncology
Figure 13. Product Picture of Neurosciences
Figure 14. Product Picture of Immunology
Figure 15. Product Picture of Respiratory
Figure 16. Product Picture of Others
Figure 17. Global Precision Medicine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 18. Global Precision Medicine Sales Value Market Share by Application, 2024 & 2031
Figure 19. North America Precision Medicine Sales Value (2020-2031) & (US$ Million)
Figure 20. North America Precision Medicine Sales Value by Country (%), 2024 VS 2031
Figure 21. Europe Precision Medicine Sales Value, (2020-2031) & (US$ Million)
Figure 22. Europe Precision Medicine Sales Value by Country (%), 2024 VS 2031
Figure 23. Asia Pacific Precision Medicine Sales Value, (2020-2031) & (US$ Million)
Figure 24. Asia Pacific Precision Medicine Sales Value by Region (%), 2024 VS 2031
Figure 25. South America Precision Medicine Sales Value, (2020-2031) & (US$ Million)
Figure 26. South America Precision Medicine Sales Value by Country (%), 2024 VS 2031
Figure 27. Middle East & Africa Precision Medicine Sales Value, (2020-2031) & (US$ Million)
Figure 28. Middle East & Africa Precision Medicine Sales Value by Country (%), 2024 VS 2031
Figure 29. Key Countries/Regions Precision Medicine Sales Value (%), (2020-2031)
Figure 30. United States Precision Medicine Sales Value, (2020-2031) & (US$ Million)
Figure 31. United States Precision Medicine Sales Value by Type (%), 2024 VS 2031
Figure 32. United States Precision Medicine Sales Value by Application (%), 2024 VS 2031
Figure 33. Europe Precision Medicine Sales Value, (2020-2031) & (US$ Million)
Figure 34. Europe Precision Medicine Sales Value by Type (%), 2024 VS 2031
Figure 35. Europe Precision Medicine Sales Value by Application (%), 2024 VS 2031
Figure 36. China Precision Medicine Sales Value, (2020-2031) & (US$ Million)
Figure 37. China Precision Medicine Sales Value by Type (%), 2024 VS 2031
Figure 38. China Precision Medicine Sales Value by Application (%), 2024 VS 2031
Figure 39. Japan Precision Medicine Sales Value, (2020-2031) & (US$ Million)
Figure 40. Japan Precision Medicine Sales Value by Type (%), 2024 VS 2031
Figure 41. Japan Precision Medicine Sales Value by Application (%), 2024 VS 2031
Figure 42. South Korea Precision Medicine Sales Value, (2020-2031) & (US$ Million)
Figure 43. South Korea Precision Medicine Sales Value by Type (%), 2024 VS 2031
Figure 44. South Korea Precision Medicine Sales Value by Application (%), 2024 VS 2031
Figure 45. Southeast Asia Precision Medicine Sales Value, (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Precision Medicine Sales Value by Type (%), 2024 VS 2031
Figure 47. Southeast Asia Precision Medicine Sales Value by Application (%), 2024 VS 2031
Figure 48. India Precision Medicine Sales Value, (2020-2031) & (US$ Million)
Figure 49. India Precision Medicine Sales Value by Type (%), 2024 VS 2031
Figure 50. India Precision Medicine Sales Value by Application (%), 2024 VS 2031
Figure 51. Precision Medicine Industrial Chain
Figure 52. Precision Medicine Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
